AlzeCure Pharma AB (publ) (ALZCUR.ST)

Sweden · Healthcare · SEK

Key financials

ROE: -161.56%; 2025 (actual)
ROA: -96.96%; 2025 (actual)
Gross Margin: -
Net Margin: -
Total Assets: SEK 59,043.00K; 2025 (actual)
Net Income: -SEK 47,654.00K; 2025 (actual)
Valuation: SEK 229,828.91K; 2025 (actual)
Stock Price: SEK 2.00; 2025 (actual)

Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for AlzeCure Pharma AB (publ)? It covers the balance sheet, income statement and Equlion model projections.